This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cell | 1916 |
immune | response | 1161 |
infectious | diseases | 1099 |
immune | responses | 974 |
antiviral | activity | 742 |
viral | infections | 676 |
- | time | 652 |
- | type | 622 |
infectious | disease | 582 |
viral | infection | 563 |
- | risk | 473 |
- | infection | 457 |
viral | proteins | 404 |
- | cells | 396 |
high | levels | 293 |
high | risk | 292 |
humans | . | 289 |
- | level | 274 |
- | hiv | 257 |
negative | . | 256 |
antiviral | effect | 248 |
antiviral | drugs | 241 |
first | time | 227 |
positive | . | 225 |
immune | cells | 211 |
viral | protein | 197 |
positive | patients | 193 |
- | protein | 191 |
other | viruses | 186 |
specific | antibodies | 178 |
viral | diseases | 175 |
severe | disease | 162 |
significant | . | 154 |
several | studies | 151 |
- | drug | 145 |
positive | results | 142 |
high | level | 141 |
other | studies | 140 |
higher | risk | 136 |
clinical | studies | 132 |
human | cells | 131 |
respiratory | infections | 131 |
low | levels | 130 |
respiratory | viruses | 127 |
- | treatment | 126 |
- | year | 125 |
- | virus | 121 |
antiviral | activities | 117 |
others | . | 117 |
antiviral | effects | 113 |
higher | levels | 107 |
different | types | 105 |
effective | treatment | 104 |
antiviral | drug | 103 |
respiratory | disease | 100 |
human | disease | 98 |
- | blood | 97 |
acute | infection | 97 |
infectious | virus | 95 |
common | . | 95 |
different | viruses | 90 |
positive | cells | 89 |
clinical | disease | 84 |
effective | . | 84 |
important | . | 84 |
other | diseases | 84 |
respiratory | infection | 84 |
specific | antibody | 84 |
viral | disease | 82 |
high | . | 81 |
negative | patients | 81 |
human | health | 80 |
antiviral | response | 77 |
severe | cases | 76 |
immune | cell | 76 |
many | viruses | 76 |
- | response | 75 |
many | patients | 74 |
- | activity | 73 |
many | studies | 72 |
low | risk | 71 |
new | hiv | 71 |
many | cases | 69 |
new | cases | 68 |
low | . | 67 |
new | infections | 67 |
- | group | 66 |
other | . | 66 |
other | groups | 65 |
many | years | 65 |
- | effects | 64 |
- | infections | 64 |
first | case | 63 |
significant | effect | 63 |
- | hiv-1 | 61 |
- | years | 61 |
human | antibody | 61 |
human | diseases | 61 |
human | infection | 61 |
low | level | 61 |
- | patient | 60 |
first | year | 60 |
respiratory | virus | 59 |
lower | levels | 59 |
- | antibody | 59 |
different | cell | 58 |
human | viruses | 58 |
- | antibodies | 57 |
positive | result | 57 |
clinical | response | 55 |
human | blood | 55 |
several | years | 55 |
negative | blood | 53 |
other | health | 51 |
other | patients | 51 |
several | viruses | 50 |
first | study | 49 |
different | methods | 49 |
different | . | 49 |
clinical | study | 48 |
other | cells | 48 |
negative | results | 47 |
other | types | 46 |
positive | antibody | 46 |
antiviral | treatment | 45 |
new | drugs | 45 |
other | infections | 45 |
significant | antibodies | 45 |
positive | blood | 44 |
such | patients | 43 |
significant | risk | 42 |
positive | effect | 41 |
specific | . | 41 |
different | time | 41 |
different | levels | 41 |
clinical | case | 41 |
more | . | 40 |
human | cell | 39 |
specific | cell | 39 |
antiviral | responses | 38 |
high | hiv | 38 |
other | blood | 38 |
high | blood | 37 |
human | cases | 37 |
other | drugs | 37 |
- | patients | 36 |
other | proteins | 35 |
several | types | 35 |
higher | level | 35 |
lower | risk | 35 |
different | blood | 35 |
- | disease | 34 |
human | infections | 34 |
other | cases | 34 |
- | groups | 33 |
respiratory | diseases | 33 |
- | case | 32 |
- | health | 32 |
many | diseases | 32 |
negative | effects | 32 |
specific | responses | 31 |
viral | response | 31 |
such | studies | 31 |
- | studied | 31 |
other | cell | 31 |
different | groups | 31 |
antiviral | protein | 30 |
severe | infections | 30 |
such | cases | 30 |
higher | . | 29 |
new | drug | 29 |
specific | treatment | 29 |
first | group | 29 |
effective | hiv | 29 |
antivirals | . | 29 |
viral | activity | 29 |
negative | result | 28 |
different | studies | 27 |
highest | risk | 27 |
new | disease | 27 |
other | methods | 27 |
such | antibodies | 27 |
acute | hiv | 26 |
human | antibodies | 26 |
specific | proteins | 26 |
infectious | . | 25 |
such | infections | 24 |
positive | cases | 24 |
other | virus | 24 |
other | risk | 24 |
new | blood | 24 |
low | blood | 24 |
highest | level | 24 |
different | proteins | 24 |
different | diseases | 24 |
- | proteins | 23 |
acute | infections | 23 |
antiviral | antibodies | 23 |
clinical | cases | 23 |
positive | patient | 23 |
human | . | 22 |
new | virus | 22 |
several | proteins | 22 |
specific | health | 21 |
more | patients | 21 |
effective | treatments | 21 |
first | patient | 20 |
lower | level | 20 |
more | time | 20 |
new | methods | 20 |
new | viruses | 20 |
several | cases | 20 |
several | times | 20 |
- | effect | 20 |
new | treatment | 19 |
specific | hiv | 19 |
several | groups | 19 |
human | proteins | 19 |
effective | method | 19 |
different | virus | 19 |
human | protein | 18 |
human | studies | 18 |
negative | effect | 18 |
other | patient | 18 |
positive | effects | 18 |
several | methods | 18 |
severe | . | 18 |
specific | response | 18 |
specific | virus | 18 |
several | cell | 17 |
positive | group | 17 |
new | method | 17 |
viral | levels | 17 |
other | hiv | 17 |
new | diseases | 17 |
first | results | 17 |
first | . | 17 |
common | infections | 17 |
infectious | viruses | 17 |
acute | disease | 17 |
specific | cells | 16 |
many | types | 16 |
viral | cell | 16 |
several | diseases | 16 |
new | treatments | 16 |
more | studies | 16 |
negative | group | 16 |
lower | . | 16 |
important | health | 16 |
first | hiv | 16 |
effective | drug | 16 |
different | cells | 16 |
antiviral | treatments | 16 |
effective | drugs | 15 |
first | blood | 15 |
many | health | 15 |
other | hiv-1 | 15 |
positive | hiv | 15 |
viral | drugs | 15 |
other | disease | 14 |
many | hiv | 14 |
new | patients | 14 |
clinical | effect | 14 |
significant | effects | 14 |
viral | effect | 14 |
many | cell | 14 |
many | groups | 14 |
acute | hiv-1 | 14 |
large | group | 14 |
important | risk | 14 |
effective | hiv-1 | 14 |
different | hiv-1 | 14 |
- | types | 14 |
anti | hiv | 14 |
infectious | risk | 14 |
other | antibodies | 13 |
such | diseases | 13 |
specific | risk | 13 |
specific | hiv-1 | 13 |
large | . | 13 |
more | cases | 13 |
first | cases | 13 |
different | times | 13 |
such | cells | 12 |
specific | blood | 12 |
specific | diseases | 12 |
immune | antibodies | 12 |
viral | activities | 12 |
other | drug | 12 |
other | treatments | 12 |
common | types | 12 |
many | infections | 12 |
- | study | 12 |
high | protein | 12 |
high | case | 12 |
- | viruses | 12 |
larger | study | 12 |
positives | . | 11 |
specific | viruses | 11 |
specific | infections | 11 |
specific | effects | 11 |
specific | disease | 11 |
specific | activity | 11 |
severe | infection | 11 |
significant | health | 11 |
new | hiv-1 | 11 |
negative | antibody | 11 |
large | blood | 11 |
effective | methods | 11 |
different | patient | 11 |
antiviral | proteins | 11 |
antiviral | antibody | 11 |
new | infection | 10 |
viral | effects | 10 |
such | treatment | 10 |
such | drugs | 10 |
significant | levels | 10 |
several | hiv-1 | 10 |
several | drugs | 10 |
positive | response | 10 |
new | type | 10 |
different | antibodies | 10 |
negatives | . | 10 |
many | blood | 10 |
infectious | hiv-1 | 10 |
higher | antibody | 10 |
high | antibody | 10 |
high | activity | 10 |
effective | blood | 10 |
common | antibody | 10 |
several | hiv | 9 |
more | drugs | 9 |
many | proteins | 9 |
other | group | 9 |
other | risks | 9 |
specific | risks | 9 |
specific | group | 9 |
specific | groups | 9 |
such | . | 9 |
immune | diseases | 9 |
important | diseases | 9 |
other | activities | 9 |
highest | levels | 9 |
different | hiv | 9 |
antiviral | . | 9 |
common | disease | 9 |
different | drugs | 9 |
different | effects | 9 |
high | virus | 9 |
effective | health | 9 |
effective | response | 9 |
- | result | 9 |
high | cell | 9 |
human | virus | 8 |
specific | type | 8 |
specific | protein | 8 |
significant | drug | 8 |
several | case | 8 |
positive | infections | 8 |
new | antibodies | 8 |
more | times | 8 |
more | hiv | 8 |
low | protein | 8 |
infectious | risks | 8 |
larger | studies | 8 |
human | type | 8 |
different | disease | 8 |
- | levels | 8 |
- | times | 8 |
common | type | 8 |
common | infection | 8 |
different | drug | 8 |
different | treatment | 8 |
higher | activity | 8 |
highest | . | 8 |
- | cases | 8 |
significant | activity | 7 |
more | diseases | 7 |
negative | patient | 7 |
new | risk | 7 |
other | study | 7 |
other | type | 7 |
such | viruses | 7 |
significant | disease | 7 |
specific | drugs | 7 |
specific | effect | 7 |
such | proteins | 7 |
many | drugs | 7 |
viral | drug | 7 |
many | virus | 7 |
significant | results | 7 |
low | virus | 7 |
clinical | results | 7 |
large | study | 7 |
- | results | 7 |
- | typed | 7 |
acute | response | 7 |
clinical | effects | 7 |
- | typing | 7 |
common | diseases | 7 |
common | methods | 7 |
common | virus | 7 |
different | results | 7 |
first | studies | 7 |
higher | case | 7 |
several | patients | 6 |
more | infections | 6 |
negative | cases | 6 |
new | risks | 6 |
new | studies | 6 |
new | study | 6 |
newer | drugs | 6 |
other | protein | 6 |
other | treatment | 6 |
specific | cases | 6 |
several | virus | 6 |
severe | hiv | 6 |
significant | antibody | 6 |
significant | infection | 6 |
significant | response | 6 |
specific | case | 6 |
many | hiv-1 | 6 |
specific | drug | 6 |
specific | patient | 6 |
such | activity | 6 |
many | methods | 6 |
largest | hiv | 6 |
many | cells | 6 |
different | protein | 6 |
- | responses | 6 |
acute | blood | 6 |
antiviral | type | 6 |
clinical | . | 6 |
clinical | risk | 6 |
low | response | 6 |
different | group | 6 |
different | patients | 6 |
common | drug | 6 |
first | virus | 6 |
higher | protein | 6 |
highest | hiv | 6 |
human | hiv-1 | 6 |
important | blood | 6 |
important | viruses | 6 |
large | studies | 6 |
large | virus | 6 |
higher | hiv | 6 |
new | case | 5 |
new | proteins | 5 |
new | group | 5 |
new | cell | 5 |
several | protein | 5 |
negative | hiv | 5 |
more | years | 5 |
more | virus | 5 |
other | case | 5 |
lower | blood | 5 |
severe | diseases | 5 |
severe | patients | 5 |
significant | blood | 5 |
specific | infection | 5 |
specific | types | 5 |
such | activities | 5 |
such | results | 5 |
such | virus | 5 |
viral | responses | 5 |
viral | treatment | 5 |
lowest | level | 5 |
lowest | risk | 5 |
low | antibody | 5 |
different | study | 5 |
largest | group | 5 |
- | methods | 5 |
acute | cases | 5 |
clinical | treatment | 5 |
common | method | 5 |
common | treatment | 5 |
common | viruses | 5 |
different | antibody | 5 |
different | risk | 5 |
antiviral | studies | 5 |
effective | risk | 5 |
first | result | 5 |
first | treatment | 5 |
higher | drug | 5 |
highest | activity | 5 |
human | case | 5 |
infectious | cases | 5 |
larger | patient | 5 |
first | cells | 5 |
more | studied | 4 |
new | level | 4 |
new | antibody | 4 |
new | . | 4 |
negative | response | 4 |
negative | cell | 4 |
more | viruses | 4 |
lower | hiv | 4 |
many | times | 4 |
many | . | 4 |
lowest | levels | 4 |
lower | protein | 4 |
low | activity | 4 |
largest | study | 4 |
other | times | 4 |
new | types | 4 |
specific | results | 4 |
positive | case | 4 |
significant | risks | 4 |
viral | risk | 4 |
such | responses | 4 |
such | effects | 4 |
such | drug | 4 |
specific | treatments | 4 |
large | effect | 4 |
significant | level | 4 |
positive | cell | 4 |
significant | hiv | 4 |
severe | health | 4 |
several | antibodies | 4 |
respiratory | cell | 4 |
positive | responses | 4 |
positive | health | 4 |
larger | viruses | 4 |
many | levels | 4 |
important | treatment | 4 |
high | health | 4 |
first | drug | 4 |
first | cell | 4 |
effective | responses | 4 |
effective | infection | 4 |
effective | cell | 4 |
different | response | 4 |
different | health | 4 |
different | effect | 4 |
different | activities | 4 |
clinical | hiv | 4 |
acute | virus | 4 |
acute | treatment | 4 |
- | drugs | 4 |
- | diseases | 4 |
important | protein | 4 |
first | type | 4 |
different | type | 4 |
high | infection | 4 |
human | study | 4 |
high | risks | 4 |
important | group | 4 |
important | effects | 4 |
important | disease | 4 |
important | cell | 4 |
immune | effects | 4 |
human | treatment | 4 |
important | hiv | 4 |
human | hiv | 4 |
human | activity | 4 |
human | activities | 4 |
higher | risks | 4 |
higher | patient | 4 |
higher | blood | 4 |
more | results | 3 |
new | protein | 3 |
new | patient | 3 |
new | health | 3 |
negative | studied | 3 |
negative | health | 3 |
negative | cells | 3 |
more | risk | 3 |
more | blood | 3 |
more | patient | 3 |
more | disease | 3 |
low | case | 3 |
lower | response | 3 |
lower | activity | 3 |
low | infection | 3 |
low | cells | 3 |
positive | infection | 3 |
other | responses | 3 |
viral | studies | 3 |
several | infections | 3 |
several | levels | 3 |
larger | groups | 3 |
viral | risks | 3 |
viral | level | 3 |
viral | antibodies | 3 |
such | response | 3 |
such | method | 3 |
such | infection | 3 |
such | effect | 3 |
such | cell | 3 |
such | case | 3 |
specific | time | 3 |
specific | methods | 3 |
significant | responses | 3 |
severe | case | 3 |
severe | blood | 3 |
larger | virus | 3 |
first | infection | 3 |
larger | group | 3 |
clinical | responses | 3 |
effective | antibodies | 3 |
different | responses | 3 |
different | level | 3 |
commonest | antibodies | 3 |
common | health | 3 |
common | drugs | 3 |
common | antibodies | 3 |
clinical | infection | 3 |
first | level | 3 |
anti | hiv-1 | 3 |
acute | drug | 3 |
acute | diseases | 3 |
- | treatments | 3 |
- | method | 3 |
large | protein | 3 |
- | . | 3 |
first | hiv-1 | 3 |
clinical | infections | 3 |
important | result | 3 |
human | patients | 3 |
large | cell | 3 |
large | health | 3 |
infectious | case | 3 |
important | study | 3 |
immune | . | 3 |
human | risk | 3 |
human | response | 3 |
first | method | 3 |
highest | virus | 3 |
higher | response | 3 |
higher | infection | 3 |
high | treatment | 3 |
high | hiv-1 | 3 |
high | disease | 3 |
high | cells | 3 |
other | studied | 2 |
newest | treatment | 2 |
other | infection | 2 |
new | groups | 2 |
many | antibodies | 2 |
other | time | 2 |
others | groups | 2 |
others | infections | 2 |
new | activity | 2 |
positive | groups | 2 |
new | cells | 2 |
more | groups | 2 |
negative | type | 2 |
negative | responses | 2 |
negative | infection | 2 |
negative | groups | 2 |
more | types | 2 |
more | protein | 2 |
more | health | 2 |
more | drug | 2 |
many | risk | 2 |
many | disease | 2 |
several | antibody | 2 |
respiratory | health | 2 |
such | methods | 2 |
several | cells | 2 |
specific | patients | 2 |
lower | infection | 2 |
viral | type | 2 |
viral | . | 2 |
such | treatments | 2 |
such | time | 2 |
such | risks | 2 |
such | patient | 2 |
such | health | 2 |
such | group | 2 |
specific | studies | 2 |
specific | level | 2 |
several | drug | 2 |
significant | treatment | 2 |
significant | protein | 2 |
significant | infections | 2 |
significant | cell | 2 |
severe | virus | 2 |
severe | group | 2 |
severe | drug | 2 |
several | time | 2 |
several | risk | 2 |
several | health | 2 |
lower | virus | 2 |
other | effects | 2 |
lower | health | 2 |
highest | infection | 2 |
high | patient | 2 |
first | years | 2 |
first | studied | 2 |
first | response | 2 |
first | disease | 2 |
first | antibody | 2 |
effective | virus | 2 |
effective | patient | 2 |
effective | levels | 2 |
effective | group | 2 |
effective | antibody | 2 |
different | infection | 2 |
common | hiv | 2 |
clinical | health | 2 |
clinical | activity | 2 |
antivirals | drugs | 2 |
antiviral | study | 2 |
antiviral | methods | 2 |
antiviral | infections | 2 |
antiviral | hiv | 2 |
acute | patients | 2 |
acute | health | 2 |
lower | cell | 2 |
higher | % | 2 |
acute | antibody | 2 |
highest | response | 2 |
infectious | patients | 2 |
human | patient | 2 |
low | treatment | 2 |
low | patient | 2 |
low | hiv | 2 |
largest | case | 2 |
larger | time | 2 |
larger | health | 2 |
large | viruses | 2 |
large | groups | 2 |
large | drug | 2 |
lower | antibody | 2 |
infectious | patient | 2 |
important | infections | 2 |
infectious | hiv | 2 |
immune | activity | 2 |
immune | health | 2 |
important | effect | 2 |
human | responses | 2 |
important | method | 2 |
important | studies | 2 |
infectious | blood | 2 |
infectious | cell | 2 |
more | cell | 1 |
negative | risk | 1 |
more | methods | 1 |
more | proteins | 1 |
more | treatment | 1 |
negative | case | 1 |
negative | disease | 1 |
negative | drug | 1 |
negative | hiv-1 | 1 |
negative | protein | 1 |
more | cells | 1 |
new | levels | 1 |
negative | study | 1 |
negative | treatment | 1 |
new | activities | 1 |
new | effects | 1 |
new | results | 1 |
newer | . | 1 |
newer | drug | 1 |
newer | methods | 1 |
non | groups | 1 |
more | antibodies | 1 |
other | activity | 1 |
non | response | 1 |
low | results | 1 |
many | treatment | 1 |
many | results | 1 |
other | response | 1 |
larger | infection | 1 |
larger | response | 1 |
larger | results | 1 |
larger | treatment | 1 |
largest | blood | 1 |
largest | risk | 1 |
largest | type | 1 |
largest | viruses | 1 |
low | cell | 1 |
low | disease | 1 |
low | health | 1 |
low | patients | 1 |
lower | cases | 1 |
lower | drug | 1 |
lower | effect | 1 |
lower | patient | 1 |
lowest | . | 1 |
lowest | activity | 1 |
many | activities | 1 |
many | antibody | 1 |
other | method | 1 |
severe | protein | 1 |
other | results | 1 |
such | levels | 1 |
severest | cases | 1 |
significant | virus | 1 |
specific | activities | 1 |
specific | levels | 1 |
specific | method | 1 |
specific | year | 1 |
specific | years | 1 |
such | antibody | 1 |
such | blood | 1 |
such | hiv-1 | 1 |
such | protein | 1 |
severe | risk | 1 |
such | result | 1 |
such | times | 1 |
such | type | 1 |
viral | antibody | 1 |
viral | cells | 1 |
viral | groups | 1 |
viral | hiv | 1 |
viral | hiv-1 | 1 |
viral | time | 1 |
viral | treatments | 1 |
severe | type | 1 |
severe | response | 1 |
other | year | 1 |
respiratory | drugs | 1 |
other | years | 1 |
others | patients | 1 |
others | risk | 1 |
others | type | 1 |
positive | disease | 1 |
positive | drug | 1 |
positive | hiv-1 | 1 |
positive | study | 1 |
positive | type | 1 |
positives | study | 1 |
respiratory | effects | 1 |
larger | cells | 1 |
respiratory | patients | 1 |
respiratory | responses | 1 |
several | activities | 1 |
several | blood | 1 |
several | effects | 1 |
several | infection | 1 |
several | risks | 1 |
several | treatment | 1 |
several | treatments | 1 |
severe | effects | 1 |
larger | effect | 1 |
immune | antibody | 1 |
larger | cell | 1 |
common | risk | 1 |
clinical | time | 1 |
clinical | treatments | 1 |
clinical | types | 1 |
clinical | virus | 1 |
common | cell | 1 |
common | effect | 1 |
common | group | 1 |
common | protein | 1 |
common | response | 1 |
common | result | 1 |
commonest | . | 1 |
effective | results | 1 |
commonest | type | 1 |
commonest | types | 1 |
different | case | 1 |
different | cases | 1 |
different | infections | 1 |
different | method | 1 |
different | treatments | 1 |
effective | activity | 1 |
effective | disease | 1 |
effective | level | 1 |
clinical | patient | 1 |
clinical | methods | 1 |
clinical | levels | 1 |
clinical | level | 1 |
- | activities | 1 |
- | effected | 1 |
- | grouped | 1 |
- | grouping | 1 |
- | resulting | 1 |
- | studies | 1 |
acute | effect | 1 |
acute | effects | 1 |
acute | risk | 1 |
acute | study | 1 |
acute | type | 1 |
acute | types | 1 |
anti | . | 1 |
antiviral | infection | 1 |
antiviral | level | 1 |
clinical | antibody | 1 |
clinical | blood | 1 |
clinical | diseases | 1 |
clinical | drug | 1 |
clinical | groups | 1 |
clinical | hiv-1 | 1 |
effective | protein | 1 |
effective | time | 1 |
larger | . | 1 |
important | proteins | 1 |
immune | disease | 1 |
immune | patients | 1 |
immune | protein | 1 |
immune | responsing | 1 |
immune | studies | 1 |
immune | type | 1 |
important | drug | 1 |
important | groups | 1 |
important | hiv-1 | 1 |
important | infection | 1 |
important | results | 1 |
first | health | 1 |
important | virus | 1 |
infectious | activity | 1 |
infectious | response | 1 |
infectious | treatment | 1 |
large | antibodies | 1 |
large | cells | 1 |
large | hiv-1 | 1 |
large | patient | 1 |
large | patients | 1 |
large | proteins | 1 |
humans | risk | 1 |
human | risks | 1 |
human | groups | 1 |
human | group | 1 |
first | patients | 1 |
first | protein | 1 |
first | resulted | 1 |
high | drug | 1 |
high | group | 1 |
higher | cell | 1 |
higher | disease | 1 |
higher | effect | 1 |
higher | effects | 1 |
higher | health | 1 |
higher | hiv-1 | 1 |
higher | responses | 1 |
higher | virus | 1 |
highest | % | 1 |
highest | antibody | 1 |
highest | blood | 1 |
highest | cell | 1 |
highest | protein | 1 |
highest | time | 1 |
human | drug | 1 |
human | drugs | 1 |
viral | types | 1 |